Kircher, Tilo and Renate Thienel (2006). «Functional brain imaging of symptoms and cognition in schizophrenia». The Boundaries of Consciousness. Amsterdam: Elsevier. σελ. 302. ISBN0-444-52876-8.
Becker T, Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement113 (429): 9–16. doi:10.1111/j.1600-0447.2005.00711.x. PMID16445476.
O'Donovan MC, Williams NM, Owen MJ (October 2003). «Recent advances in the genetics of schizophrenia». Hum. Mol. Genet.12 Spec No 2: R125–33. doi:10.1093/hmg/ddg302. PMID12952866.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (January 2010). «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies». Int. J. Drug Policy21 (1): 10–9. doi:10.1016/j.drugpo.2009.09.001. PMID19783132.
O'Donovan MC, Craddock NJ, Owen MJ (July 2009). «Genetics of psychosis; insights from views across the genome». Hum. Genet.126 (1): 3–12. doi:10.1007/s00439-009-0703-0. PMID19521722.
Crow TJ (July 2008). «The 'big bang' theory of the origin of psychosis and the faculty of language». Schizophrenia Research102 (1–3): 31–52. doi:10.1016/j.schres.2008.03.010. PMID18502103.
Selten JP, Cantor-Graae E, Kahn RS (March 2007). «Migration and schizophrenia». Current Opinion in Psychiatry20 (2): 111–115. doi:10.1097/YCO.0b013e328017f68e. PMID17278906.
Broome MR, Woolley JB, Tabraham P, et al. (November 2005). «What causes the onset of psychosis?». Schizophr. Res.79 (1): 23–34. doi:10.1016/j.schres.2005.02.007. PMID16198238.
Kurtz MM (2005). «Neurocognitive impairment across the lifespan in schizophrenia: an update». Schizophrenia Research74 (1): 15–26. doi:10.1016/j.schres.2004.07.005. PMID15694750.
Cohen AS, Docherty NM (2004). «Affective reactivity of speech and emotional experience in patients with schizophrenia». Schizophrenia Research69 (1): 7–14. doi:10.1016/S0920-9964(03)00069-0. PMID15145465.
Horan WP, Blanchard JJ (2003). «Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping». Schizophrenia Research60 (2–3): 271–83. doi:10.1016/S0920-9964(02)00227-X. PMID12591589.
Smith B, Fowler DG, Freeman D, et al. (September 2006). «Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations». Schizophr. Res.86 (1–3): 181–8. doi:10.1016/j.schres.2006.06.018. PMID16857346.
Beck, AT (2004). «A Cognitive Model of Schizophrenia». Journal of Cognitive Psychotherapy18 (3): 281–88. doi:10.1891/jcop.18.3.281.65649.
Bell V, Halligan PW, Ellis HD (2006). «Explaining delusions: a cognitive perspective». Trends in Cognitive Science10 (5): 219–26. doi:10.1016/j.tics.2006.03.004. PMID16600666.
Green MF (2006). «Cognitive impairment and functional outcome in schizophrenia and bipolar disorder». Journal of Clinical Psychiatry67 (Suppl 9): 3–8. doi:10.4088/jcp.1006e12. PMID16965182.
Jones HM, Pilowsky LS (2002). «Dopamine and antipsychotic drug action revisited». British Journal of Psychiatry181: 271–275. doi:10.1192/bjp.181.4.271. PMID12356650.
Konradi C, Heckers S (2003). «Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment». Pharmacology and Therapeutics97 (2): 153–79. doi:10.1016/S0163-7258(02)00328-5. PMID12559388.
Jakobsen KD, Frederiksen JN, Hansen T, et al. (2005). «Reliability of clinical ICD-10 schizophrenia diagnoses». Nordic Journal of Psychiatry59 (3): 209–12. doi:10.1080/08039480510027698. PMID16195122.
Tandon R, Gaebel W, Barch DM, et al. (October 2013). «Definition and description of schizophrenia in the DSM-5». Schizophr. Res.150 (1): 3–10. doi:10.1016/j.schres.2013.05.028. PMID23800613.
Barch DM, Bustillo J, Gaebel W, et al. (October 2013). «Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5». Schizophr. Res.150 (1): 15–20. doi:10.1016/j.schres.2013.04.027. PMID23706415.
McGlashan TH (February 1987). «Testing DSM-III symptom criteria for schizotypal and borderline personality disorders». Archives of General Psychiatry44 (2): 143–8. doi:10.1001/archpsyc.1987.01800140045007. PMID3813809.
Marshall, M; Rathbone, J (Jun 15, 2011). «Early intervention for psychosis.». The Cochrane database of systematic reviews (6): CD004718. doi:10.1002/14651858.CD004718.pub3. PMID21678345.
de Koning MB, Bloemen OJ, van Amelsvoort TA, et al. (June 2009). «Early intervention in patients at ultra high risk of psychosis: benefits and risks». Acta Psychiatr Scand119 (6): 426–42. doi:10.1111/j.1600-0447.2009.01372.x. PMID19392813.
Hartling L, Abou-Setta AM, Dursun S, et al. (14 August 2012). «Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine157 (7): 498–511. doi:10.7326/0003-4819-157-7-201210020-00525. PMID22893011.
Taylor DM (2000). «Refractory schizophrenia and atypical antipsychotics». J Psychopharmacol14 (4): 409–418. doi:10.1177/026988110001400411.
Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009). «Clozapine versus typical neuroleptic medication for schizophrenia». Cochrane Database of Systematic Reviews (1): CD000059. doi:10.1002/14651858.CD000059.pub2. PMID19160174.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (April 2004). «Neuroleptic malignant syndrome and atypical antipsychotic drugs». Journal of Clinical Psychiatry65 (4): 464–70. doi:10.4088/JCP.v65n0403. PMID15119907.
Pharoah F, Mari J, Rathbone J, Wong W (2010). «Family intervention for schizophrenia». Cochrane Database of Systematic Reviews12 (12): CD000088. doi:10.1002/14651858.CD000088.pub3. PMID21154340.
Jauhar S, McKenna PJ, Radua J, et al. (January 2014). «Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias». The British journal of psychiatry : the journal of mental science204 (1): 20–9. doi:10.1192/bjp.bp.112.116285. PMID24385461.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). «Cognitive behaviour therapy for schizophrenia». Cochrane Database of Systematic Reviews (4): CD000524. doi:10.1002/14651858.CD000524.pub2. PMID15495000.
Laursen TM, Munk-Olsen T, Vestergaard, M (March 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry25 (2): 83–8. doi:10.1097/YCO.0b013e32835035ca. PMID22249081.
Erlangsen, A; Eaton, WW; Mortensen, PB; Conwell, Y (Feb 2012). «Schizophrenia--a predictor of suicide during the second half of life?». Schizophrenia research134 (2-3): 111–7. doi:10.1016/j.schres.2011.09.032. PMID22018943.
Saha S, Chant D, McGrath J (October 2007). «A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?». Arch. Gen. Psychiatry64 (10): 1123–31. doi:10.1001/archpsyc.64.10.1123. PMID17909124.
Ustun TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J, και ο WHO/National Institutes of Health (1999). «Multiple-informant ranking of the disabling effects of different health conditions in 14 countries». The Lancet354 (9173): 111–15. doi:10.1016/S0140-6736(98)07507-2. PMID10408486.
Burns J (August 2009). «Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia». Afr J Psychiatry (Johannesbg)12 (3): 200–5. doi:10.4314/ajpsy.v12i3.48494. PMID19894340.
Palmer BA, Pankratz VS, Bostwick JM (March 2005). «The lifetime risk of suicide in schizophrenia: a reexamination». Archives of General Psychiatry62 (3): 247–53. doi:10.1001/archpsyc.62.3.247. PMID15753237.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (July 2010). «Suicide in schizophrenia». Expert Rev Neurother10 (7): 1153–64. doi:10.1586/ern.10.82. PMID20586695.
De Leon J, Diaz FJ (2005). «A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors». Schizophrenia research76 (2-3): 135–57. doi:10.1016/j.schres.2005.02.010. PMID15949648.
Cascio MT, Cella M, Preti A, Meneghelli A, Cocchi A (May 2012). «Gender and duration of untreated psychosis: a systematic review and meta-analysis». Early intervention in psychiatry6 (2): 115–27. doi:10.1111/j.1751-7893.2012.00351.x. PMID22380467.
Jablensky A, Sartorius N, Ernberg G, et al. (1992). «Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study». Psychological Medicine Monograph Supplement20: 1–97. doi:10.1017/S0264180100000904. PMID1565705.
Kirkbride JB, Fearon P, Morgan C, et al. (March 2006). «Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study». Archives of General Psychiatry63 (3): 250–8. doi:10.1001/archpsyc.63.3.250. PMID16520429.
Kirkbride JB, Fearon P, Morgan C, et al. (2007). «Neighbourhood variation in the incidence of psychotic disorders in Southeast London». Social Psychiatry and Psychiatric Epidemiology42 (6): 438–45. doi:10.1007/s00127-007-0193-0. PMID17473901.
Becker T, Kilian R (2006). «Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care?». Acta Psychiatrica Scandinavica Supplement113 (429): 9–16. doi:10.1111/j.1600-0447.2005.00711.x. PMID16445476.
O'Donovan MC, Williams NM, Owen MJ (October 2003). «Recent advances in the genetics of schizophrenia». Hum. Mol. Genet.12 Spec No 2: R125–33. doi:10.1093/hmg/ddg302. PMID12952866.
McLaren JA, Silins E, Hutchinson D, Mattick RP, Hall W (January 2010). «Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies». Int. J. Drug Policy21 (1): 10–9. doi:10.1016/j.drugpo.2009.09.001. PMID19783132.
O'Donovan MC, Craddock NJ, Owen MJ (July 2009). «Genetics of psychosis; insights from views across the genome». Hum. Genet.126 (1): 3–12. doi:10.1007/s00439-009-0703-0. PMID19521722.
Crow TJ (July 2008). «The 'big bang' theory of the origin of psychosis and the faculty of language». Schizophrenia Research102 (1–3): 31–52. doi:10.1016/j.schres.2008.03.010. PMID18502103.
Selten JP, Cantor-Graae E, Kahn RS (March 2007). «Migration and schizophrenia». Current Opinion in Psychiatry20 (2): 111–115. doi:10.1097/YCO.0b013e328017f68e. PMID17278906.
Kurtz MM (2005). «Neurocognitive impairment across the lifespan in schizophrenia: an update». Schizophrenia Research74 (1): 15–26. doi:10.1016/j.schres.2004.07.005. PMID15694750.
Cohen AS, Docherty NM (2004). «Affective reactivity of speech and emotional experience in patients with schizophrenia». Schizophrenia Research69 (1): 7–14. doi:10.1016/S0920-9964(03)00069-0. PMID15145465.
Horan WP, Blanchard JJ (2003). «Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping». Schizophrenia Research60 (2–3): 271–83. doi:10.1016/S0920-9964(02)00227-X. PMID12591589.
Smith B, Fowler DG, Freeman D, et al. (September 2006). «Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations». Schizophr. Res.86 (1–3): 181–8. doi:10.1016/j.schres.2006.06.018. PMID16857346.
Bell V, Halligan PW, Ellis HD (2006). «Explaining delusions: a cognitive perspective». Trends in Cognitive Science10 (5): 219–26. doi:10.1016/j.tics.2006.03.004. PMID16600666.
Green MF (2006). «Cognitive impairment and functional outcome in schizophrenia and bipolar disorder». Journal of Clinical Psychiatry67 (Suppl 9): 3–8. doi:10.4088/jcp.1006e12. PMID16965182.
Jones HM, Pilowsky LS (2002). «Dopamine and antipsychotic drug action revisited». British Journal of Psychiatry181: 271–275. doi:10.1192/bjp.181.4.271. PMID12356650.
Konradi C, Heckers S (2003). «Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment». Pharmacology and Therapeutics97 (2): 153–79. doi:10.1016/S0163-7258(02)00328-5. PMID12559388.
Jakobsen KD, Frederiksen JN, Hansen T, et al. (2005). «Reliability of clinical ICD-10 schizophrenia diagnoses». Nordic Journal of Psychiatry59 (3): 209–12. doi:10.1080/08039480510027698. PMID16195122.
Tandon R, Gaebel W, Barch DM, et al. (October 2013). «Definition and description of schizophrenia in the DSM-5». Schizophr. Res.150 (1): 3–10. doi:10.1016/j.schres.2013.05.028. PMID23800613.
Barch DM, Bustillo J, Gaebel W, et al. (October 2013). «Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5». Schizophr. Res.150 (1): 15–20. doi:10.1016/j.schres.2013.04.027. PMID23706415.
McGlashan TH (February 1987). «Testing DSM-III symptom criteria for schizotypal and borderline personality disorders». Archives of General Psychiatry44 (2): 143–8. doi:10.1001/archpsyc.1987.01800140045007. PMID3813809.
Marshall, M; Rathbone, J (Jun 15, 2011). «Early intervention for psychosis.». The Cochrane database of systematic reviews (6): CD004718. doi:10.1002/14651858.CD004718.pub3. PMID21678345.
de Koning MB, Bloemen OJ, van Amelsvoort TA, et al. (June 2009). «Early intervention in patients at ultra high risk of psychosis: benefits and risks». Acta Psychiatr Scand119 (6): 426–42. doi:10.1111/j.1600-0447.2009.01372.x. PMID19392813.
Hartling L, Abou-Setta AM, Dursun S, et al. (14 August 2012). «Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-generation versus second-generation medications: a systematic review and meta-analysis». Annals of Internal Medicine157 (7): 498–511. doi:10.7326/0003-4819-157-7-201210020-00525. PMID22893011.
Schultz SH, North SW, Shields CG (June 2007). «Schizophrenia: a review». Am Fam Physician75 (12): 1821–9. PMID17619525.
Smith T, Weston C, Lieberman J (August 2010). «Schizophrenia (maintenance treatment)». Am Fam Physician82 (4): 338–9. PMID20704164.
Essali A, Al-Haj Haasan N, Li C, Rathbone J (2009). «Clozapine versus typical neuroleptic medication for schizophrenia». Cochrane Database of Systematic Reviews (1): CD000059. doi:10.1002/14651858.CD000059.pub2. PMID19160174.
Ananth J, Parameswaran S, Gunatilake S, Burgoyne K, Sidhom T (April 2004). «Neuroleptic malignant syndrome and atypical antipsychotic drugs». Journal of Clinical Psychiatry65 (4): 464–70. doi:10.4088/JCP.v65n0403. PMID15119907.
McEvoy JP (2006). «Risks versus benefits of different types of long-acting injectable antipsychotics». J Clin Psychiatry67 Suppl 5: 15–8. PMID16822092.
Pharoah F, Mari J, Rathbone J, Wong W (2010). «Family intervention for schizophrenia». Cochrane Database of Systematic Reviews12 (12): CD000088. doi:10.1002/14651858.CD000088.pub3. PMID21154340.
Jauhar S, McKenna PJ, Radua J, et al. (January 2014). «Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias». The British journal of psychiatry : the journal of mental science204 (1): 20–9. doi:10.1192/bjp.bp.112.116285. PMID24385461.
Jones C, Cormac I, Silveira da Mota Neto JI, Campbell C (2004). «Cognitive behaviour therapy for schizophrenia». Cochrane Database of Systematic Reviews (4): CD000524. doi:10.1002/14651858.CD000524.pub2. PMID15495000.
Laursen TM, Munk-Olsen T, Vestergaard, M (March 2012). «Life expectancy and cardiovascular mortality in persons with schizophrenia». Current opinion in psychiatry25 (2): 83–8. doi:10.1097/YCO.0b013e32835035ca. PMID22249081.
Erlangsen, A; Eaton, WW; Mortensen, PB; Conwell, Y (Feb 2012). «Schizophrenia--a predictor of suicide during the second half of life?». Schizophrenia research134 (2-3): 111–7. doi:10.1016/j.schres.2011.09.032. PMID22018943.
Saha S, Chant D, McGrath J (October 2007). «A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?». Arch. Gen. Psychiatry64 (10): 1123–31. doi:10.1001/archpsyc.64.10.1123. PMID17909124.
Ustun TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J, και ο WHO/National Institutes of Health (1999). «Multiple-informant ranking of the disabling effects of different health conditions in 14 countries». The Lancet354 (9173): 111–15. doi:10.1016/S0140-6736(98)07507-2. PMID10408486.
Isaac M, Chand P, Murthy P (August 2007). «Schizophrenia outcome measures in the wider international community». Br J Psychiatry Suppl50: s71–7. PMID18019048.
Burns J (August 2009). «Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia». Afr J Psychiatry (Johannesbg)12 (3): 200–5. doi:10.4314/ajpsy.v12i3.48494. PMID19894340.
Palmer BA, Pankratz VS, Bostwick JM (March 2005). «The lifetime risk of suicide in schizophrenia: a reexamination». Archives of General Psychiatry62 (3): 247–53. doi:10.1001/archpsyc.62.3.247. PMID15753237.
Carlborg A, Winnerbäck K, Jönsson EG, Jokinen J, Nordström P (July 2010). «Suicide in schizophrenia». Expert Rev Neurother10 (7): 1153–64. doi:10.1586/ern.10.82. PMID20586695.
De Leon J, Diaz FJ (2005). «A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors». Schizophrenia research76 (2-3): 135–57. doi:10.1016/j.schres.2005.02.010. PMID15949648.
Cascio MT, Cella M, Preti A, Meneghelli A, Cocchi A (May 2012). «Gender and duration of untreated psychosis: a systematic review and meta-analysis». Early intervention in psychiatry6 (2): 115–27. doi:10.1111/j.1751-7893.2012.00351.x. PMID22380467.
Jablensky A, Sartorius N, Ernberg G, et al. (1992). «Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study». Psychological Medicine Monograph Supplement20: 1–97. doi:10.1017/S0264180100000904. PMID1565705.
Kirkbride JB, Fearon P, Morgan C, et al. (March 2006). «Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study». Archives of General Psychiatry63 (3): 250–8. doi:10.1001/archpsyc.63.3.250. PMID16520429.
Kirkbride JB, Fearon P, Morgan C, et al. (2007). «Neighbourhood variation in the incidence of psychotic disorders in Southeast London». Social Psychiatry and Psychiatric Epidemiology42 (6): 438–45. doi:10.1007/s00127-007-0193-0. PMID17473901.